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RatsAbstract The current study was undertaken to evaluate the protective activity of olive and rose-
mary leaves extracts on experimental liver cirrhosis induced by thioacetamide (TAA) in Wistar male
rats. Highly signiﬁcant decline in the values of body weight gain and highly statistically increase of
liver/body weight ratio were noted in rats treated with TAA. Furthermore, the levels of serum
alanine aminotransferase, aspartate aminotransferase, gamma glutamyl transferase, alkaline phos-
phatase and total bilirubin were statistically increased. Additionally, light microscopic examination
of liver sections from rats treated with TAA showed a marked increase in the extracellular matrix
collagen content and bridging ﬁbrosis was prominent. There were bundles of collagen surrounding
the lobules that resulted in large ﬁbrous septa and distorted tissue architecture. Interestingly, the
ﬁndings of this experimental study indicated that the extracts of olive and rosemary leaves and their
combination possess hepatoprotective properties against TAA-induced hepatic cirrhosis by inhibit-
ing the physiological and histopathological alterations. Moreover, these results suggest that the
hepatoprotective effects of these extracts may be attributed to their antioxidant activities.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Liver or hepatic cirrhosis affects hundreds of millions of
patients worldwide. Liver cirrhosis is the terminal stage of var-
ious chronic liver diseases (Gressner, 1996; Schuppan and
Afdhal, 2008). Moreover, the majority of patients worldwide
with hepatocellular carcinoma (HCC) have underlying livercirrhosis, supported by the fact that in 80% of autopsies of
patients with HCC, cirrhosis is found (Simonetti et al., 1991).
Thioacetamide (TAA), also known as thioacetimidic acid,
or acetothioamide (CH3CSNH2), was originally used as a fun-
gicide (Vadi and Neal, 1981). Moreover, many experimental
studies showed that TAA induced liver ﬁbrosis and cirrhosis
in experimental animals (Al-Attar, 2011, 2012; Wang et al.,
2012; Fatima and Mahboob, 2013; Shao et al., 2014).
Recently, World Health Organization (WHO) deﬁned
traditional medicine (including herbal drugs) as therapeutic
practices that have been in existence, often for hundreds of
years, before the development and spread of modern medicine
and are still in use today (Kashaw et al., 2011). The olive tree
(Olea europaea L.), family: Oleaceae, and in particular, its
leaves have been used for the treatment of wounds, fever, dia-
betes, gout, atherosclerosis and hypertension since ancient
158 A.M. Al-Attar, N.A. Shawushtimes (Ja¨nicke et al., 2003). Rosemary (Rosmarinus ofﬁcinalis
Linn.), mint (Labiatae) family, is a common household plant
grown in many parts of the world. It is commonly used as a
spice and ﬂavoring agent in food processing (Saito et al.,
2004). However, rosemary and its constituents have a thera-
peutic potential in treatment or prevention of many physiolog-
ical, biochemical and histopathological alterations (al-Sereiti
et al., 1999; Osakabe et al., 2004; Sancheti and Goyal 2006;
Gaya et al., 2013). The purpose of the present study is to
compare the effects of olive and rosemary leaves extracts on
experimental liver cirrhosis induced by TAA in rats.
2. Materials and methods
2.1. Animals
Male albino rats of the Wistar strain (Rattus norvegicus),
weighing 72.6–103.4 g were used in the present study. The
experimental animals were obtained from the Experimental
Animal Unit of King Fahd Medical Research Center, King
Abdulaziz University, Jeddah, Saudi Arabia. Rats were
acclimatized to the laboratory conditions for 10 days prior to
the initiation of experimental treatments. The experimental
animals were housed in standard plastic cages and maintained
under controlled laboratory conditions of humidity (65%),
temperature (20 ± 1 C) and 12:12 h light:dark cycle. Rats
were fed ad libitum on normal commercial chow and had free
access to water. The experimental treatments were conducted
in accordance with ethical guidelines of the Animal Care and
Use Committee of King Abdulaziz University.
2.2. Olive and rosemary leaf extraction
Olive and rosemary leaves of ﬁne quality were obtained from a
commercial market, Jeddah, Saudi Arabia. The leaves were
thoroughly washed and dried at room temperature. The
methods of Sakr and Lamfon (2012), and Al-Attar and Abu
Zeid (2013) were used to prepare the extracts with some mod-
iﬁcations. The dried olive leaves (50 g) were powdered and
added to 2 liters of hot water in a ﬂask. After 6 h, the mixture
was slowly boiled for 1 h. After boiling period, the mixture was
cooled at room temperature and it was gently subjected to an
electric mixer for 10 min. Also, the dried rosemary leaves (50 g)
were powdered and added to 2 liters of hot water in a ﬂask.
After 6 h, the mixture was slowly boiled for 1 h. After boiling
period, the mixture was cooled at room temperature and it was
gently subjected to an electric mixer for 10 min. Thereafter the
solutions of olive and rosemary leaves were ﬁltered. Finally,
the ﬁltrates were evaporated in an oven at 40 C to produce
dried residues (active principles). With references to the pow-
dered samples, the yields means of the olive and rosemary
extracts were 18.7% and 20.6% respectively. Furthermore,
these extracts were prepared every 2 weeks and stored in a
refrigerator for subsequent experiments.
2.3. Experimental design
A total of forty-eight rats were randomly divided into eight
experimental groups, six of rats each. The experimental groups
were treated as follows:1. Rats of group 1 were served as controls and intraperitone-
ally injected with saline solution (0.9% NaCl), twice weekly
for twelve weeks.
2. Rats of group 2 were given 300 mg/kg body weight of TAA
(Sigma–Aldrich Corp., St. Louis, MO, USA) by intraperi-
toneal injection, twice weekly for twelve weeks.
3. Rats of group 3 were intraperitoneally injected with TAA at
the same dose given to group 2 and were orally supple-
mented with olive leaves extract at a dose of 200 mg/kg
body weight/day for twelve weeks.
4. Rats of group 4 were intraperitoneally injected with TAA at
the same dose given to group 2 and were orally supple-
mented with rosemary leaves extract at a dose of 200 mg/
kg body weight/day for twelve weeks.
5. Animals of group 5 were intraperitoneally injected with
TAA at the same dose given to group 2 and were orally
supplemented with olive leaves extract (100 mg/kg body
weight/day) and rosemary leaves extract (100 mg/kg body
weight/day) for twelve weeks.
6. Rats of group 6 were intraperitoneally received saline
solution at the same dose given to group 1 and were orally
supplemented with olive leaves extract at the same dose
given to group 3 for twelve weeks.
7. Animals of group 7 were intraperitoneally received saline
solution at the same dose given to group 1 and were orally
supplemented with rosemary leaves extract at the same dose
given to group 4 for twelve weeks.
8. Rats of group 8 were intraperitoneally received saline
solution at the same dose given to group 1 and were supple-
mented with olive and rosemary leaves extracts at the same
dose given to group 5 for twelve weeks.
2.4. Body weight determinations
The body weights of rats were determined at the start of the
experimental period and after twelve weeks using a digital bal-
ance. These weights were measured at the same time during the
morning (Al-Attar and Zari, 2010). Moreover, the experimen-
tal animals were observed for signs of abnormalities through-
out the period of study.2.5. Blood serum analyses
After twelve weeks, the experimental animals were fasted
for 12 h, water was not restricted, and then anaesthetized
with diethyl ether. Blood samples were collected from orbi-
tal venous plexus in non-heparinized tubes, centrifuged at
2500 rpm for 15 min and blood sera were then collected
and stored at 4 C prior immediate determination of ala-
nine aminotransferase (ALT), aspartate aminotransferase
(AST), gamma glutamyl transferase (GGT), alkaline phos-
phatase (ALP) and total bilirubin. The method of
Reitman and Frankel (1957) was used to determine the
levels of serum ALT and AST. Serum GGT level was
measured according to the method of Szasz (1969). The
method of MacComb and Bowers (1972) was carried out
to determine the level of serum ALP. Total bilirubin
concentration was determined using the method of
Doumas et al. (1973).
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After blood sampling, rats were dissected and the liver tissues
were preserved in 10% buffered formalin immediately after
removal from the animals, embedded with parafﬁn. After
routine processing, parafﬁn sections of each tissue were cut
into 4 lm thickness and stained with hematoxylin and eosin.
Moreover, liver sections were subjected to Masson’s trichrome
stain. All liver sections were examined using a light microscope
and photographed.
2.7. Weight changes of liver
After twelve weeks, livers were carefully excised and weighed
for the evaluation of their ratios/body weight. The ratio was
calculated by the following equation:
Ratio ¼ Liver weight
Body weight
 100treated rats.2.8. Statistical analysis
The data were analyzed using the Statistical Package for Social
Sciences (SPSS for windows, version 12.0). Each value is
expressed as mean ± standard deviation (S.D.) and values
were analyzed using two-way analysis of variance (ANOVA)
to determine differences between the mean values of experi-
mental groups. P-values of less than 0.05 were considered as
signiﬁcant.
3. Results
Fig. 1 demonstrates the changes of body weights of all exper-
imental groups after twelve weeks. Signiﬁcant decreases in the
values of body weight gain were observed in rats treated with
TAA, TAA plus olive leaves extract, TAA plus rosemary
leaves extract, and TAA plus olive and rosemary leaves
extracts. The minimum body weight gain was noted in TAA-
intoxicated rats (220.1%). The maximum body weight gain
was noted in normal control rats (381.0%). Supplementation
with the tested extracts showed remarkable lowering effect
on the percentage changes of body weight in rats treated with
TAA plus olive leaves extract, TAA plus rosemary leaves
extract, and TAA plus olive and rosemary leaves extracts0
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Figure 1 Changes of body weight in control (group 1), TAA (group
leaves extract (group 4), TAA plus olive and rosemary leaves extracts
(group 7), and olive and rosemary leaves extracts (group 8) treated rawhich amounted 251.5%, 266.9% and 254.9% respectively.
Oral administration of tested extracts to normal rats caused
signiﬁcant increases in body weight gain. The change of body
weight gain was 286.9% in normal rats supplemented with
olive leaves extract. Supplementation with rosemary leaves
extract in normal rats showed a remarkable increase of the
percentage change of body weight (301.4%). The percentage
change of body weight gain in normal rats fed with olive and
rosemary leaves extracts is 297.6%. In comparison with
normal control rats, notably increases in the values of liver/
body weight ratio were observed in TAA (73.7%), TAA plus
olive leaves extract (57.8%), TAA plus rosemary leaves extract
(46.0%), and TAA plus olive and rosemary leaves extracts
(58.5%) treated rats. The values of liver/body weight ratio
were statistically unchanged in normal rats supplemented with
olive leaves extract, rosemary leaves extract, and olive and
rosemary leaves extracts (Fig. 2).
TAA administration to normal rats signiﬁcantly elevated
the level of serum ALT (1521.5%) compared with control rats
and other treated groups. The levels of this parameter were
statistically increased in rats with TAA plus olive leaves extract
(401.3%), TAA plus rosemary leaves extract (308.4%), and
TAA plus olive and rosemary leaves extracts (359.1%). As5 6 7 8
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160 A.M. Al-Attar, N.A. Shawushshown in Table 1, signiﬁcant elevations in the level of serum
AST were noted in TAA (1113.8%), TAA plus olive leaves
extract (258.3%), TAA plus rosemary leaves extract
(131.4%), and TAA plus olive and rosemary leaves extracts
(187.4%) treated rats compared with control rats. Remarkable
elevations in the level of serum GGT were observed in rats
treated with TAA (374.9%), TAA plus olive leaves extract
(71.0%), TAA plus rosemary leaves extract (56.3%), and
TAA plus olive and rosemary leaves extracts (43.2%) when
compared to control rats. The levels of serum ALP were statis-
tically increased in rats treated with TAA (604.7%), TAA plus
olive leaves extract (43.0%), TAA plus rosemary leaves extract
(25.7%), and TAA plus olive and rosemary leaves extracts
(32.6%). Notable increases in the level of serum total bilirubin
were observed in rats treated with TAA (215.2%), TAA plus
olive leaves extract (55.6%), TAA plus rosemary leaves extract
(56.2%), and TAA plus olive and rosemary leaves extracts
(77.9%) as compared with control group. On the other hand,
insigniﬁcant changes of serum ALT, AST, GGT, ALP and
total bilirubin levels were observed in olive leaves extract, rose-
mary leaves extract, and olive and rosemary leaves extracts
treated rats as compared with control rats (Table 1).
Light microscopic examination indicated a normal structure
of the liver in the control rats (Fig. 3A) as well as the rats trea-
ted with olive leaves extract (Fig. 3J), rosemary leaves extract
(Fig. 3K), and olive and rosemary leaves extracts (Fig. 3L).
In the rats treated with only TAA, there was a marked increase
in the extracellular matrix collagen content and bridging ﬁbro-
sis was prominent. There were bundles of collagen surrounding
the lobules that resulted in large ﬁbrous septa and distorted tis-
sue architecture. The administration of TAA induced nodular
transformations in liver parenchyma similar to those found in
human nodular cirrhosis. Moreover, the parenchyma nodules
were surrounded by extensive of ﬁbrous septae which divided
the liver into pseudolobules. TAA administration induced cen-
trilobular necrosis, hepatic cells surrounding central vein
showed various degenerative changes like cloudy swelling,
hydropic degeneration and necrosis with loss of nucleus
(Fig. 3B and C). In rats treated with TAA plus olive leaves
extract (Fig. 3D and E), TAA plus rosemary leaves extract
(Fig. 3F and G), TAA plus olive and rosemary leaves extracts
(Fig. 3H and I), liver sections showed that the degree of ﬁbrosis
was substantially less than the TAA-alone treated rats. Fur-
thermore, the liver cells showed slight alterations compared
with liver cells structure of rats treated with only TAA. Addi-
tionally, there are no any obvious features of hepatic cirrhosis
in rats treated with TAA plus olive leaves extract, TAA plus
rosemary leaves extract, and TAA plus olive and rosemary
leaves extracts.
4. Discussion
Hepatic injuries lead to attenuation of metabolic functions
regulated by liver, and has remained one of the serious health
problems (Wolf, 1999) threatening the human society. Cirrho-
sis is the endpoint of the ﬁbrogenic process that accompanies
chronic liver injury, and complications arising from cirrhosis
are the ultimate cause of death in many patients with chronic
liver disease (Friedman, 2006). Despite recent therapeutic
advances, many liver diseases remain relentlessly progressive
because speciﬁc therapies to target the underlying etiologies
Figure 3 (A–L) Photomicrographs of liver sections in each group. (A) control (200·), (B and C) TAA (40· and 200·), (D and E) TAA
plus olive leaves extract (100· and 200·), (F and G) TAA plus rosemary leaves extract (100· and 200·), (H and I) TAA plus olive and
rosemary leaves extracts (100· and 200·), (J) olive leaves extract (200·), (K) rosemary leaves extract (200·), and (L) olive and rosemary
leaves extracts (200·) treated rats.
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162 A.M. Al-Attar, N.A. Shawushof the liver diseases are not available. Therefore, the demand
for liver transplantation is likely to increase unless more effec-
tive therapeutic and antiﬁbrotic agents are developed.
The present study demonstrated that TAA at a dose of
300 mg/kg body weight, twice weekly for a period of 12 weeks
induced hepatic cirrhosis with many histopathological
alterations in male Wistar rats. TAA intoxication has shown
a dramatic decrease in the percentage of body weight gain
and signiﬁcant increases in the relative weights of body liver.
Moreover, the obtained results showed an elevation in the
levels of serum ALT, AST, GGT, ALP and total bilirubin.
Similar observations were noted in experimental animals trea-
ted with TAA (Al-Attar, 2011, 2012; Salama et al., 2013;
Zargar, 2014; Kim et al., 2014).
The obtained results showed that the treatment of rats with
olive and rosemary leaves extracts or their combination
improved the physiological and histopathological alterations
induced by TAA intoxication. This indicated the effectiveness
of these extracts in prevention of TAA toxicity. Hierarchically,
the current study revealed that the most effective treatment
was rosemary leaves extract followed by the combination of
olive and rosemary leaves extracts and olive leaves extract
The possible mechanism of the studied extracts as hepatopro-
tective factors may be due to its antioxidant effect which
impair the activation of TAA into the reactive form. Bruck
et al. (2004) stated that the chronic of TAA administration
induced liver cirrhosis and oxidative stress. Aydin et al.
(2010) showed that TAA administration resulted in hepatic
ﬁbrosis, signiﬁcant increases in plasma transaminase activities
as well as hepatic hydroxyproline and lipid peroxide levels,
while liver glutathione (GSH) and superoxide dismutase
(SOD) and glutathione peroxidase (GSH-Px) protein expres-
sions and activities decreased. Al-Attar (2012) reported that
the levels of liver SOD and GSH were signiﬁcantly decreased
in mice treated with TAA. Additionally, many investigations
indicated that TAA caused a signiﬁcant decrease in the levels
of liver SOD and GSH (Uskokovic´-Markovic´ et al., 2007;
Mansour and El-Kabany, 2009; Kantah et al., 2011; Fatima
and Mahboob, 2013).
The main constituent of the olive leaves is oleuropein, one
of iridoide monoterpenes, which is thought to be responsible
for pharmacological effects. Furthermore, the olive leaves con-
tain triterpenes (oleanolic and maslinic acid), ﬂavonoides (e.g.,
luteolin, apigenine, rutin), and chalcones such as olivin, olivin-
diglucoside (Meirinhos et al. 2005; Pereira et al. 2007). It was
shown that total olive leaves extract had antioxidant activity
higher than vitamin C and vitamin E, due to the synergy
between ﬂavonoids, oleuropeosides and substituted phenols
(Benavente-Garcia et al., 2000). Khalil (2004) investigated
the hepatoprotective activity of an aqueous extract of olive
leaves against overdose paracetamol in male albino rats. She
concluded that an aqueous extract of olive leaves has antioxi-
dant property which can protect liver damage occurred by
overdose paracetamol in male albino rats.
Rosemary, via one of its active constituents rosmarinic acid
(RA), is often used by herbalists and naturopaths for its
beneﬁcial effects on the liver disease. Li et al. (2010)
investigated the potential effects of RA on hepatic ﬁbrosis,
the consequence of sustained wound healing responses by the
liver. Cultures of hepatic stellate cells (HSCs) were used for
in vitro assessment and tetrachloride treated rats as in vivosubjects. They reported that RA could prevent hepatic ﬁbrosis
due to chronic liver damage and thus delay cirrhosis
development. Abdel-Wahhab et al. (2011) investigated the
chemoprotective effect of rosemary extract against CCl4-induced
hepatotoxicity in adult male Wistar albino rats. Administration
of rosemary extract before or during the treatment with CCl4
improved all biochemical parameters and histological picture of
the liver. They reported that rosemary extract has a protective
effect against hepatotoxicity and this extract inhibited and
reduced the CCl4-induced hepatotoxicity in rats possibly by
scavenging or blocking the formation of free radicals generated
during CCl4 metabolism. These improving effects of rosemary
could be attributed to the bioactive constituents that alleviated
the deleterious effect of CCl4 either by the well-known scavenging
action or the antioxidant properties that inhibited lipid
peroxidation, stabilized the reactive radicals, preserve the
cellular integrity and restrain the severity of CCl4.
One of the most important ﬁndings in the present study is
the observation that the studied extracts of olive and rosemary
leaves and their combination were effective in reducing the
TAA induced liver cirrhosis, that were proven by physiological
analysis and histopathological evaluation. Collectively, the
results of this study suggest that the effects of these extracts
against TAA-induced hepatic cirrhosis possibly due to
antioxidant properties of their natural chemical constituents.
Moreover, this study is from the ﬁrst investigations that apply
scientiﬁc methodology to looking at how these extracts exert
its role in the protection action against physiological
disturbances and histopathological alterations in hepatic
cirrhosis cases and may be in its complications. Additional
physiological, biochemical and histopathological investiga-
tions are needed to explore the possible use of different doses
of these extracts and their constituents as potential natural
therapeutic agents in therapy of hepatic cirrhosis against
TAA and may be against other ﬁbrogenic factors.
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